Intra-Cellular Therapies Inc (ITCI)
73.26
+1.13
(+1.57%)
USD |
NASDAQ |
Apr 26, 16:00
73.33
+0.07
(+0.10%)
After-Hours: 20:00
Intra-Cellular Therapies Shareholders Equity (Quarterly): 591.42M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 591.42M |
| September 30, 2023 | 600.68M |
| June 30, 2023 | 607.09M |
| March 31, 2023 | 627.61M |
| December 31, 2022 | 656.07M |
| September 30, 2022 | 685.42M |
| June 30, 2022 | 722.20M |
| March 31, 2022 | 792.75M |
| December 31, 2021 | 417.89M |
| September 30, 2021 | 486.76M |
| June 30, 2021 | 553.59M |
| March 31, 2021 | 612.15M |
| December 31, 2020 | 656.86M |
| September 30, 2020 | 709.40M |
| June 30, 2020 | 379.53M |
| March 31, 2020 | 430.45M |
| December 31, 2019 | 195.01M |
| September 30, 2019 | 226.88M |
| June 30, 2019 | 256.77M |
| March 31, 2019 | 288.61M |
| December 31, 2018 | 317.71M |
| September 30, 2018 | 353.63M |
| Date | Value |
|---|---|
| June 30, 2018 | 390.39M |
| March 31, 2018 | 423.19M |
| December 31, 2017 | 454.44M |
| September 30, 2017 | 319.44M |
| June 30, 2017 | 339.67M |
| March 31, 2017 | 353.03M |
| December 31, 2016 | 375.50M |
| September 30, 2016 | 399.32M |
| June 30, 2016 | 425.96M |
| March 31, 2016 | 452.74M |
| December 31, 2015 | 476.24M |
| September 30, 2015 | 501.85M |
| June 30, 2015 | 203.57M |
| March 31, 2015 | 222.38M |
| December 31, 2014 | 120.55M |
| September 30, 2014 | 134.03M |
| June 30, 2014 | 138.60M |
| March 31, 2014 | 142.72M |
| December 31, 2013 | 31.62M |
| September 30, 2013 | 39.56M |
| June 30, 2013 | -0.033M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
195.01M
Minimum
Dec 2019
792.75M
Maximum
Mar 2022
537.29M
Average
600.68M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 68.77B |
| Insmed Inc | -331.92M |
| Vertex Pharmaceuticals Inc | 17.58B |
| Fate Therapeutics Inc | 368.42M |
| ADMA Biologics Inc | 135.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 728.30M |
| Total Liabilities (Quarterly) | 136.87M |
| Current Ratio | 5.405 |